Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021788
Company: TEVA WOMENS
Company: TEVA WOMENS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SYNTHETIC CONJUGATED ESTROGENS A | ESTROGENS, CONJUGATED SYNTHETIC A | 0.625MG/GM | CREAM;VAGINAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/28/2008 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021788lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021788s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021788_synthetic_conjugated_estrogens_toc.cfm |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 11/28/2008 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021788lbl.pdf |